ABSTRACT Objective: To assess medication-related costs in patients with open-angle glaucoma subjected to iStent inject®. Methods: Retrospective study of patients with early-stage open-angle glaucoma who underwent iStent inject® implantation within the Brazilian private healthcare system and were followed for a period of 1 to 5 years. The study population comprised 234 patients with a mean age of 68.4 years old. The capacity to reduce intraocular pressure, amount of antiglaucoma medications required, and monthly cost of the necessary antiglaucoma medications during […]